153 related articles for article (PubMed ID: 16703288)
1. IMRT in hypopharyngeal tumors.
Studer G; Lütolf UM; Davis JB; Glanzmann C
Strahlenther Onkol; 2006 Jun; 182(6):331-5. PubMed ID: 16703288
[TBL] [Abstract][Full Text] [Related]
2. IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients.
Studer G; Huguenin PU; Davis JB; Kunz G; Lütolf UM; Glanzmann C
Radiat Oncol; 2006 Mar; 1():7. PubMed ID: 16722599
[TBL] [Abstract][Full Text] [Related]
3. Surviving hypopharynx-larynx carcinoma in the era of IMRT.
Studer G; Peponi E; Kloeck S; Dossenbach T; Huber G; Glanzmann C
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1391-6. PubMed ID: 20056352
[TBL] [Abstract][Full Text] [Related]
4. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx.
Clark CH; Bidmead AM; Mubata CD; Harrington KJ; Nutting CM
Radiother Oncol; 2004 Feb; 70(2):189-98. PubMed ID: 15028407
[TBL] [Abstract][Full Text] [Related]
6. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
Lee NY; O'Meara W; Chan K; Della-Bianca C; Mechalakos JG; Zhung J; Wolden SL; Narayana A; Kraus D; Shah JP; Pfister DG
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):459-68. PubMed ID: 17493769
[TBL] [Abstract][Full Text] [Related]
7. Treatment techniques and site considerations regarding dysphagia-related quality of life in cancer of the oropharynx and nasopharynx.
Teguh DN; Levendag PC; Noever I; van Rooij P; Voet P; van der Est H; Sipkema D; Sewnaik A; Baatenburg de Jong RJ; de la Bije D; Schmitz PI
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1119-27. PubMed ID: 18472364
[TBL] [Abstract][Full Text] [Related]
8. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma.
Lee NY; de Arruda FF; Puri DR; Wolden SL; Narayana A; Mechalakos J; Venkatraman ES; Kraus D; Shaha A; Shah JP; Pfister DG; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):966-74. PubMed ID: 17145527
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of IMRT for breast cancer: a single-institution cohort analysis.
McDonald MW; Godette KD; Butker EK; Davis LW; Johnstone PA
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1031-40. PubMed ID: 18440727
[TBL] [Abstract][Full Text] [Related]
10. Local high-dose radiotherapy and sparing of normal tissue using intensity-modulated radiotherapy (IMRT) for mucosal melanoma of the nasal cavity and paranasal sinuses.
Combs SE; Konkel S; Thilmann C; Debus J; Schulz-Ertner D
Strahlenther Onkol; 2007 Feb; 183(2):63-8. PubMed ID: 17294109
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma.
Kim K; Wu HG; Kim HJ; Sung MW; Kim KH; Lee SH; Heo DS; Kim HJ; Park CI
Head Neck; 2009 Sep; 31(9):1121-8. PubMed ID: 19340863
[TBL] [Abstract][Full Text] [Related]
12. Locoregional failure analysis in head-and-neck cancer patients treated with IMRT.
Studer G; Luetolf UM; Glanzmann C
Strahlenther Onkol; 2007 Aug; 183(8):417-23; discussion 424-5. PubMed ID: 17680220
[TBL] [Abstract][Full Text] [Related]
13. Osteoradionecrosis of the mandible: minimized risk profile following intensity-modulated radiation therapy (IMRT).
Studer G; Studer SP; Zwahlen RA; Huguenin P; Grätz KW; Lütolf UM; Glanzmann C
Strahlenther Onkol; 2006 May; 182(5):283-8. PubMed ID: 16673062
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer.
Madani I; Vakaet L; Bonte K; Boterberg T; De Neve W
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1158-66. PubMed ID: 18258383
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
16. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067
[TBL] [Abstract][Full Text] [Related]
17. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome.
Milano MT; Chmura SJ; Garofalo MC; Rash C; Roeske JC; Connell PP; Kwon OH; Jani AB; Heimann R
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):445-53. PubMed ID: 15145161
[TBL] [Abstract][Full Text] [Related]
19. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
Guerrero Urbano T; Clark CH; Hansen VN; Adams EJ; A'Hern R; Miles EA; McNair H; Bidmead M; Warrington AP; Dearnaley DP; Harrington KJ; Nutting CM
Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
[TBL] [Abstract][Full Text] [Related]
20. Decreased short- and long-term swallowing problems with altered radiotherapy dosing used in an organ-sparing protocol for advanced pharyngeal carcinoma.
Smith RV; Goldman SY; Beitler JJ; Wadler SS
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):831-6. PubMed ID: 15262759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
